Antigen Cross-Presentation by Type-2 Innate Lymphoid Cells Facilitates the Activation of Antitumor CD8+ T Cells
Type-2 innate lymphoid cells process and present tumor antigens to CD8+ T cells to increase cytotoxic activity against cancer cells, highlighting the potential to harness this intercellular interaction to improve cancer treatment.
Authors
- Sang‐Jun Ha (ORCID: https://orcid.org/0000-0002-1192-6031)
- Yong‐Soo Bae (ORCID: https://orcid.org/0000-0002-2233-9449)
- Suhyun Park
- Jongho Ham (ORCID: https://orcid.org/0000-0001-9423-2053)
- Doo Hyun Chung
- Seung Geun Song (ORCID: https://orcid.org/0000-0002-1605-2708)
- Young Gyun Ko (ORCID: https://orcid.org/0000-0002-1477-6833)
- Hye Young Kim (ORCID: https://orcid.org/0000-0001-5978-512X)
- Jihyun Kim (ORCID: https://orcid.org/0000-0003-1222-0345)
- Tae Soo Kim (ORCID: https://orcid.org/0000-0002-3902-1058)
Institutions
- Ewha Womans University (KR)
- Seoul National University (KR)
- Yonsei University (KR)
- New Generation University College (ET)
- Seoul National University Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Cancer Research
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1158/0008-5472.can-24-4194
- Citations
- 3
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- National Research Foundation of Korea